ResearchBib Share Your Research, Maximize Your Social Impacts
Sign for Notice Everyday Sign up >> Login

Hypoglycemic and antidyslipidemic potential of Pleurotus ostreatus in streptozotocin-induced diabetic rats

Journal: Journal of Advanced Biotechnology and Experimental Therapeutics (Vol.3, No. 1)

Publication Date:

Authors : ; ; ; ; ; ; ; ; ;

Page : 49-55

Keywords : Pleurotusostreatus; anti-hyperglycemic; antidyslipidemic; blood glucose level; lipid profile.;

Source : Downloadexternal Find it from : Google Scholarexternal

Abstract

Oyster Mushroom (Pleurotusostreatus), an edible mushroom, is traditionally being used as a curing. However, hypoglycemic as well as antidyslipidemic effects on methanolic and ethyl acetate extracts of oyster mushroom in streptozotocin-treated diabetic rat model was not investigated yet. Here, we investigated that oral administration of 200 mg/kg oyster mushroom for 30 days were estimated through evaluating the fasting blood glucose level and blood lipid profile of diabetic rat. The results from our studies explained that P. ostreatusoyster mushroom considerably decreased blood glucose level initiated after treatment on second week. However, oyster mushroom was significantly reduced in plasma triglycerides (TG), total cholesterol (TC), as well as low-density lipoprotein-cholesterol (LDL-C). Additionally, high density lipoprotein-cholesterol (HDL-C) was enhanced by the treatment of oyster mushroom. Therefore, the current study suggests that P. ostreatus has antihyperglycemic and anti-dyslipidemic effect on streptozotocin-induce diabetic rat model.

Last modified: 2020-12-21 19:51:04